Company intelligence / Profile preview

Alto Opportunity Master Fund SPC

Grand Cayman, Cayman Islands

Ownership: Private
Development stage: Other

Overview

Alto Opportunity Master Fund SPC is a Cayman Islands-based hedge fund managed by Ayrton Capital LLC and operates as a segregated portfolio company. It is not a biotech, pharmaceutical, or healthcare company, nor does it develop or commercialize therapeutics. Instead, its activities center around asset management and investment, sometimes investing in healthcare-related businesses or participating in settlements with such companies, but it does not itself have a scientific or clinical development pipeline.

Industry: Investors

Partnerships

Sometimes participates in investment or settlement agreements (e.g., with Genius Group)

Beyond the preview

Go deeper on Alto Opportunity Master Fund SPC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alto Opportunity Master Fund SPC.

Explore the full profile